Boston Advisors’s Eastman Chemical EMN Stock Holding History
Bought
Maintained
Sold
Other funds holding EMN
Boston Advisors's EMN Position: Q3 2019 in Review
Boston Advisors reduced its Eastman Chemical (EMN) stake by 7.9% in Q3 2019, selling an estimated $39.5K and leaving 6,400 shares worth $473K. The position accounts for 0.02% of the portfolio, ranked #467.
Boston Advisors first reported a position in EMN in Q2 2013 and has held it in 26 quarters since. The position peaked at $16M in Q2 2014. 623 funds tracked by Wall St. Rank hold EMN as of Q3 2019.
- Boston Advisors held 6,400 shares of Eastman Chemical worth $473K as of Q3 2019.
- Boston Advisors sold 550 Eastman Chemical shares in Q3 2019, an estimated $39.5K.
- Eastman Chemical made up 0.02% of Boston Advisors's portfolio in Q3 2019, its #467 holding.
- Boston Advisors first reported a position in Eastman Chemical in Q2 2013 and has held it in 26 quarters since.
- Boston Advisors's Eastman Chemical position peaked at $16M in Q2 2014.
- 623 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2019.
Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.